Michael Trentalange is an author at Amgen (United States) specializing in medicine, immunotherapy, and natural sciences.
Top concepts
MedicineImmunologyImmunotherapyNatural SciencesMolecular BiologyAntibody EngineeringVirologyMetabolismProteomicsVaccination
Publications per year
2008–2016
3
3
CHO cell production and sequence improvement in the 13C6FR1 anti-Ebola antibody
Dean K. Pettit, Richard S. Rogers, Kelly K. Arthur et al. · mAbs · 2016 · 22 citations · Full text
Rows per page
1–3 of 3